When it comes to the performance of healthcare companies during the pandemic, the author of today’s article notes that “Those best prepared for developing a vaccine for Covid have had excellent returns, while companies working on other pressing healthcare issues have struggled.” Some firms that have struggled, however, could be poised for an excellent year – presenting traders with market-beating opportunities. Here’s one such biotech company – and how traders may want to play it. CLICK HERE.
This Biotech Laggard Could Offer Traders A Market-Beating Opportunity
- by Alex Clarke
